W Robert Lee

Summary

Affiliation: Wake Forest University School of Medicine
Country: USA

Publications

  1. ncbi request reprint Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27
    W R Lee
    Wake Forest University School of Medicine, Winston Salem, NC 27157 1030, USA
    Int J Radiat Oncol Biol Phys 42:1069-75. 1998
  2. ncbi request reprint Changes in graduate medical education: a view from radiation oncology
    W Robert Lee
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157 1030, USA
    J Am Coll Radiol 1:576-82. 2004
  3. ncbi request reprint Dosimetry and cancer control after low-dose-rate prostate brachytherapy
    W Robert Lee
    Radiation Oncology, Winston Salem, NC 27157, USA
    Int J Radiat Oncol Biol Phys 61:52-9. 2005
  4. ncbi request reprint The 1999 patterns of care study of radiotherapy in localized prostate carcinoma: a comprehensive survey of prostate brachytherapy in the United States
    W Robert Lee
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, USA
    Cancer 98:1987-94. 2003
  5. ncbi request reprint A phase II study of external beam radiotherapy combined with permanent source brachytherapy for intermediate-risk, clinically localized adenocarcinoma of the prostate: preliminary results of RTOG P-0019
    W Robert Lee
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, NC 27157 1030, USA
    Int J Radiat Oncol Biol Phys 64:804-9. 2006
  6. ncbi request reprint Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy
    W Robert Lee
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, NC 27157 1030, USA
    Int J Radiat Oncol Biol Phys 54:457-61. 2002
  7. ncbi request reprint A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy
    W R Lee
    Comprehensive Cancer Center of Wake Forest University School of Medicine, Winston Salem, NC 27157 1030, USA
    Int J Radiat Oncol Biol Phys 51:614-23. 2001
  8. ncbi request reprint Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: evidence for a learning curve in the first year at a single institution
    W R Lee
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, NC 27157 1030, USA
    Int J Radiat Oncol Biol Phys 46:83-8. 2000
  9. ncbi request reprint A preliminary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer
    W R Lee
    Department of Radiation Oncology, Comprehensive Cancer Center of the Wake Forest University School of Medicine, Winston Salem, NC 27157 1030, USA
    Int J Radiat Oncol Biol Phys 46:77-81. 2000
  10. doi request reprint Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate
    Colleen A Lawton
    Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, USA
    Int J Radiat Oncol Biol Phys 82:e795-801. 2012

Detail Information

Publications55

  1. ncbi request reprint Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27
    W R Lee
    Wake Forest University School of Medicine, Winston Salem, NC 27157 1030, USA
    Int J Radiat Oncol Biol Phys 42:1069-75. 1998
    ....
  2. ncbi request reprint Changes in graduate medical education: a view from radiation oncology
    W Robert Lee
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157 1030, USA
    J Am Coll Radiol 1:576-82. 2004
    ..This change presents new challenges to teachers of radiation oncology. With the help of the ACR and other institutions, radiation oncology is well positioned to meet this challenge...
  3. ncbi request reprint Dosimetry and cancer control after low-dose-rate prostate brachytherapy
    W Robert Lee
    Radiation Oncology, Winston Salem, NC 27157, USA
    Int J Radiat Oncol Biol Phys 61:52-9. 2005
    ....
  4. ncbi request reprint The 1999 patterns of care study of radiotherapy in localized prostate carcinoma: a comprehensive survey of prostate brachytherapy in the United States
    W Robert Lee
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, USA
    Cancer 98:1987-94. 2003
    ..The objective of the current study was to provide descriptive information on a representative national sample of patients with prostate carcinoma who were treated with prostate brachytherapy (PB) in calendar year 1999...
  5. ncbi request reprint A phase II study of external beam radiotherapy combined with permanent source brachytherapy for intermediate-risk, clinically localized adenocarcinoma of the prostate: preliminary results of RTOG P-0019
    W Robert Lee
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, NC 27157 1030, USA
    Int J Radiat Oncol Biol Phys 64:804-9. 2006
    ..To estimate the rate of acute and late Grade 3-5 genitourinary and gastrointestinal toxicity after treatment with external beam radiotherapy and permanent source brachytherapy in a multi-institutional, cooperative group setting...
  6. ncbi request reprint Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy
    W Robert Lee
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, NC 27157 1030, USA
    Int J Radiat Oncol Biol Phys 54:457-61. 2002
    ..To compare the prostate gland volumes and subsequent quantifiers of implant adequacy determined by five separate brachytherapists on postimplant CT images performed 1 day after prostate brachytherapy...
  7. ncbi request reprint A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy
    W R Lee
    Comprehensive Cancer Center of Wake Forest University School of Medicine, Winston Salem, NC 27157 1030, USA
    Int J Radiat Oncol Biol Phys 51:614-23. 2001
    ..To prospectively assess the health-related quality of life (HRQOL) and changes in HRQOL during the first year after 3 different treatments for clinically localized prostate cancer...
  8. ncbi request reprint Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: evidence for a learning curve in the first year at a single institution
    W R Lee
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, NC 27157 1030, USA
    Int J Radiat Oncol Biol Phys 46:83-8. 2000
    ..The purpose of this report is to critically analyze the dosimetric coverage achieved following TIPPB in the first 63 cases performed by a multidisciplinary group of investigators with no prior experience with TIPPB...
  9. ncbi request reprint A preliminary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer
    W R Lee
    Department of Radiation Oncology, Comprehensive Cancer Center of the Wake Forest University School of Medicine, Winston Salem, NC 27157 1030, USA
    Int J Radiat Oncol Biol Phys 46:77-81. 2000
    ..To prospectively assess the health-related quality of life (HRQOL) and changes in HRQOL during the first year after permanent source interstitial brachytherapy (PIB)...
  10. doi request reprint Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate
    Colleen A Lawton
    Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, USA
    Int J Radiat Oncol Biol Phys 82:e795-801. 2012
    ..This report defines the long-term results of this trial...
  11. pmc Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer
    Jeff M Michalski
    Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 76:361-8. 2010
    ..To define a prostate fossa clinical target volume (PF-CTV) for Radiation Therapy Oncology Group (RTOG) trials using postoperative radiotherapy for prostate cancer...
  12. ncbi request reprint A simple model predicts freedom from biochemical recurrence after low-dose rate prostate brachytherapy alone
    Michael A Papagikos
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA
    Am J Clin Oncol 30:199-204. 2007
    ..The objective of this study was to describe a simple model that predicts freedom from biochemical recurrence (FFBR) in men with prostate cancer after treatment with low-dose rate prostate brachytherapy (LDRPB) alone...
  13. ncbi request reprint Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of Radiation Therapy Oncology Group study 0019
    W Robert Lee
    Department of Radiation Oncology, Duke University School of Medicine, Durham, North Carolina 27710, USA
    Cancer 109:1506-12. 2007
    ....
  14. ncbi request reprint Dosimetric quantifiers for low-dose-rate prostate brachytherapy: is V(100) superior to D(90)?
    Michael A Papagikos
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, NC 27157 1030, USA
    Brachytherapy 4:252-8. 2005
    ....
  15. doi request reprint Robot-assisted laparoscopic prostatectomy is not associated with early postoperative radiation therapy
    Junzo Chino
    Radiation Oncology, Duke University Medical Center, Durham, NC, USA
    BJU Int 104:1496-500. 2009
    ....
  16. ncbi request reprint Results of a phase II trial of transrectal ultrasound-guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (radiation therapy oncology group 98-05)
    Colleen A Lawton
    Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Int J Radiat Oncol Biol Phys 67:39-47. 2007
    ....
  17. doi request reprint Impact of primary Gleason grade on risk stratification for Gleason score 7 prostate cancers
    Bridget F Koontz
    Department of Radiation Oncology, Duke Prostate Center, Duke University Medical Center, Durham, NC 27710, USA
    Int J Radiat Oncol Biol Phys 82:200-3. 2012
    ..To evaluate the primary Gleason grade (GG) in Gleason score (GS) 7 prostate cancers for risk of non-organ-confined disease with the goal of optimizing radiotherapy treatment option counseling...
  18. doi request reprint Pretreatment prostate-specific antigen velocity is associated with freedom from biochemical recurrence of prostate cancer after low-dose-rate prostate brachytherapy alone
    Peter J Rossi
    Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA
    Brachytherapy 7:286-9. 2008
    ..This report examines the relationship between pretreatment prostate-specific antigen (PSA) velocity (PSAV) and freedom from biochemical recurrence (FFBR) in men with prostate cancer treated with low-dose-rate prostate brachytherapy (LDRPB)...
  19. ncbi request reprint A descriptive analysis of postimplant dosimetric parameters from Radiation Therapy Oncology Group P0019
    W Robert Lee
    Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
    Brachytherapy 5:239-43. 2006
    ..To date, there are few descriptive analyses of postimplant dosimetry from multi-institutional clinical trials. The purpose of this report is to describe the postimplant dosimetry achieved in Radiation Therapy Oncology Group (RTOG) 0019...
  20. ncbi request reprint Prostate brachytherapy: a descriptive analysis from CaPSURE
    W Robert Lee
    Department of Radiation Oncology, Duke University School of Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Brachytherapy 6:123-8. 2007
    ....
  21. pmc Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas
    Hiram A Gay
    Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO 63110 6311, USA
    Int J Radiat Oncol Biol Phys 83:e353-62. 2012
    ..To define a male and female pelvic normal tissue contouring atlas for Radiation Therapy Oncology Group (RTOG) trials...
  22. doi request reprint Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes
    Sua Yoo
    Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
    Int J Radiat Oncol Biol Phys 76:935-42. 2010
    ..Dosimetric results and treatment delivery efficiency of RapidArc plans to those of conventional intensity-modulated radiotherapy (IMRT) plans were compared using the Eclipse treatment planning system for high-risk prostate cancer...
  23. ncbi request reprint Comparison of online IGRT techniques for prostate IMRT treatment: adaptive vs repositioning correction
    Danthai Thongphiew
    Department of Radiation Oncology, Duke University Medical Center, P O Box 3295, Durham, North Carolina 27710, USA
    Med Phys 36:1651-62. 2009
    ....
  24. ncbi request reprint Radiation dose to the neurovascular bundles or penile bulb does not predict erectile dysfunction after prostate brachytherapy
    Rex A Kiteley
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, NC 27157 1030, USA
    Brachytherapy 1:90-4. 2002
    ..To examine the relationship between calculated doses to the neurovascular bundles (NVBs) and the penile bulb (PB) and the development of erectile dysfunction (ED) after low-dose-rate prostate brachytherapy (LDRPB) alone...
  25. ncbi request reprint Cancer control after low-dose-rate prostate brachytherapy performed by a multidisciplinary team with no previous prostate brachytherapy experience
    Kevin P McMullen
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157 1030, USA
    Urology 63:1128-31. 2004
    ..To describe the biochemical disease-free survival observed in the first cohort men treated by a multidisciplinary team of clinicians with no previous experience in low-dose-rate prostate brachytherapy (LDRPB)...
  26. ncbi request reprint Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer
    Peter J Rossi
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157 1030, USA
    Urology 67:349-53. 2006
    ..The PPBs has been associated with FFBR in men treated with radical prostatectomy and external beam radiotherapy for prostate cancer...
  27. ncbi request reprint Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05
    Steven J Feigenberg
    Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111 2497, USA
    Int J Radiat Oncol Biol Phys 62:956-64. 2005
    ..To prospectively assess health-related quality of life (HRQOL) during the first year after treatment with prostate brachytherapy (PB) alone for T1c-2a prostate cancer...
  28. doi request reprint Incorporating gross anatomy education into radiation oncology residency: a 2-year curriculum with evaluation of resident satisfaction
    Alvin R Cabrera
    Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA
    J Am Coll Radiol 8:335-40. 2011
    ..In this report, the authors document their experience with a 2-year curriculum...
  29. doi request reprint Development and clinical evaluation of a three-dimensional cone-beam computed tomography estimation method using a deformation field map
    Lei Ren
    Department of Radiation Oncology, Henry Ford Health System, Detroit, MI, USA
    Int J Radiat Oncol Biol Phys 82:1584-93. 2012
    ..To develop a three-dimensional (3D) cone-beam computed tomography (CBCT) estimation method using a deformation field map, and to evaluate and optimize the efficiency and accuracy of the method for use in the clinical setting...
  30. doi request reprint Adaptive prostate IGRT combining online re-optimization and re-positioning: a feasibility study
    Taoran Li
    Department of Radiation Oncology, Duke University Medical Centre, Durham, NC, USA
    Phys Med Biol 56:1243-58. 2011
    ..AIGRT is also seen to provide improved OAR sparing compared to re-positioning. Apart from dosimetric benefits, AIGRT in addition offers an efficient scheme to integrate re-optimization to current re-positioning-based IGRT workflow...
  31. doi request reprint Morbidity and prostate-specific antigen control of external beam radiation therapy plus low-dose-rate brachytherapy boost for low, intermediate, and high-risk prostate cancer
    Bridget F Koontz
    Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
    Brachytherapy 8:191-6. 2009
    ..The purpose of this study was to determine cancer control and morbidity of external beam radiation therapy (EBRT) plus low-dose-rate (LDR) BT boost in patients with prostate cancer treated at Duke University Health System...
  32. ncbi request reprint The role of androgen deprivation therapy combined with prostate brachytherapy
    W Robert Lee
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA
    Urology 60:39-44; discussion 44. 2002
    ..ADT may lead to increased acute urinary morbidity and decreased erectile function after PB. No substantial effects of ADT on disease-free survival are apparent. Prospective randomized trials of PB and ADT are required...
  33. pmc Results from the Quality Research in Radiation Oncology (QRRO) survey: Evaluation of dosimetric outcomes for low-dose-rate prostate brachytherapy
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Brachytherapy 12:19-24. 2013
    ..We report on quality of dose delivery to target and normal tissues from low-dose-rate prostate brachytherapy using postimplantation dosimetric evaluations from a random sample of U.S. patients...
  34. ncbi request reprint External beam radiation therapy for clinically localized prostate cancer: when and how we optimize with concurrent hormonal deprivation
    Bridget F Koontz
    Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Arch Esp Urol 64:858-64. 2011
    ..This review discusses the clinical trial data regarding combination of androgen deprivation and radiation and provides recommendations for its use in men undergoing radiotherapy for localized prostate cancer...
  35. ncbi request reprint A structured literature review to determine the use of the American Society for Therapeutic Radiology and Oncology consensus definition of biochemical failure
    Kevin P McMullen
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, USA
    Urology 61:391-6. 2003
    ..The present analysis examined the extent to which the ACD has been used in the peer-reviewed published literature and how frequently the PGs have been followed...
  36. doi request reprint On-line re-optimization of prostate IMRT plans for adaptive radiation therapy
    Q Jackie Wu
    Department of Radiation Oncology, Duke University Medical Center Durham, NC, USA
    Phys Med Biol 53:673-91. 2008
    ..The feasibility of this technique is demonstrated with a clinical case with large deformation. Such on-line ART process can be highly valuable with hypo-fractionated prostate IMRT treatment...
  37. ncbi request reprint Does a delay in initiating definitive therapy affect biochemical recurrence rates in men with clinically localized prostate cancer?
    Joseph J Phillips
    Department of Urology, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA
    Urol Oncol 25:196-200. 2007
    ..To assess whether a delay in initiating definitive therapy for clinically localized prostate cancer affects outcome...
  38. ncbi request reprint Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy
    Peter E Clark
    Department of Urology and Comprehensive Cancer Center, Wake Forest University Health Sciences, Winston Salem, North Carolina 27157, USA
    Urology 67:1257-61. 2006
    ..To report a prospective trial of lycopene supplementation in biochemically relapsed prostate cancer...
  39. ncbi request reprint Publication rate of abstracts from the annual ASTRO meeting: comparison with other organizations
    Michael A Papagikos
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, USA
    J Am Coll Radiol 2:72-5. 2005
    ..The purpose of this study was to determine the publication rate of abstracts accepted for oral presentation at ASTRO's 1999, 2000, and 2001 annual meetings...
  40. pmc Single institution's dosimetry and IGRT analysis of prostate SBRT
    Q Jackie Wu
    Department of Radiation Oncology, Duke University Medical Center, Box 3295, Durham, NC 27710, USA
    Radiat Oncol 8:215. 2013
    ..To report single institution's IGRT and dosimetry analysis on the 37 Gy/5 fraction prostate SBRT clinical trial...
  41. doi request reprint Quantitative analysis of the factors which affect the interpatient organ-at-risk dose sparing variation in IMRT plans
    Lulin Yuan
    Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
    Med Phys 39:6868-78. 2012
    ....
  42. doi request reprint Radiotherapy following radical prostatectomy
    Pretesh Patel
    Department of Radiation Oncology, Duke University School of Medicine, Durham, NC 27710, USA
    Expert Rev Anticancer Ther 12:973-9. 2012
    ..This article will review the evidence, provide a commentary on the existing evidence, and describe key issues going forward (timing of radiotherapy, androgen suppression and radiotherapy techniques)...
  43. ncbi request reprint Update on brachytherapy in localized prostate cancer: the importance of dosimetry
    James J Urbanic
    Department of Radiation Oncology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston Salem, NC 27157, USA
    Curr Opin Urol 16:157-61. 2006
    ..In this review, we will focus on the importance of dosimetric quantifiers in predicting freedom from biochemical recurrence...
  44. doi request reprint Hypofractionation for clinically localized prostate cancer
    Alvin R Cabrera
    Department of Radiation Oncology, Duke Cancer Institute, Durham, NC 27710, USA
    Semin Radiat Oncol 23:191-7. 2013
    ..Over the next several years, the results of 3 large noninferiority trials of moderate hypofractionation and 2 randomized trials of extreme hypofractionation should help clarify the role of hypofractionation in prostate cancer therapy...
  45. doi request reprint Radiation therapy for prostate cancer
    Bridget F Koontz
    Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
    Surg Oncol Clin N Am 22:483-94. 2013
    ..Herein we briefly discuss the indications, results, and complications associated with brachytherapy and external beam radiotherapy, when used as monotherapy and in combination with each other or androgen deprivation...
  46. ncbi request reprint Confidence intervals and survival estimates: a systematic review of 3 oncology journals
    James J Urbanic
    Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, NC 27157 1030, USA
    Am J Clin Oncol 29:405-7. 2006
    ..Confidence intervals (CI) provide a range of values that is likely to contain the true result. We hypothesized that reporting of CI around survival estimates is not uniform...
  47. doi request reprint Extreme hypofractionation for prostate cancer
    W Robert Lee
    Duke University School of Medicine, Department of Radiation Oncology, DUMC, Durham, NC 27710, USA
    Expert Rev Anticancer Ther 9:61-5. 2009
    ..This critical article examines two methods that represent schedules at the extreme end of the fractionation spectrum (3-5 fractions): high-dose-rate brachytherapy as monotherapy and stereotactic body radiotherapy...
  48. ncbi request reprint Male breast cancer during treatment with leuprolide for prostate cancer
    Joseph Yacoub
    Department of Radiation Oncology, Wake Forest University, Winston Salem, NC 27157, USA
    Clin Adv Hematol Oncol 5:555-6; discussion 556-7. 2007
  49. doi request reprint Carcinoma of the urethra: radiation oncology
    Bridget F Koontz
    Department of Radiation Oncology, Duke University Medical Center, Durham, NC 22710, USA
    Urol Clin North Am 37:459-66. 2010
    ..Although literature is limited to case reports because of the rarity of the disease, the markedly improved results compared with older results of surgery with or without radiation warrant consideration...
  50. pmc On-line adaptive radiation therapy: feasibility and clinical study
    Taoran Li
    Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
    J Oncol 2010:407236. 2010
    ..In addition, a clinical implementation scheme for ART is designed and evaluated using clinical cases for its dosimetric qualities and efficiency...
  51. doi request reprint American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy
    Brian J Davis
    Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
    Brachytherapy 11:6-19. 2012
    ..To provide updated American Brachytherapy Society (ABS) guidelines for transrectal ultrasound-guided transperineal interstitial permanent prostate brachytherapy (PPB)...
  52. doi request reprint Teaching the anatomy of oncology: evaluating the impact of a dedicated oncoanatomy course
    Junzo P Chino
    Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA
    Int J Radiat Oncol Biol Phys 79:853-9. 2011
    ..We developed an anatomy-focused educational program for radiation oncology residents integrating cadaver dissection into the didactic review of diagnostic, surgical, radiologic, and treatment planning, and herein assess its efficacy...
  53. doi request reprint Adjuvant versus salvage radiation therapy for prostate cancer and the risk of death
    Anthony V D'Amico
    Brigham and Women s Hospital and Dana Farber Cancer Institute, Department of Radiation Oncology, Boston, MA, USA
    BJU Int 106:1618-22. 2010
    ....
  54. ncbi request reprint Computer-based learning in medical education: a critical view
    W Robert Lee
    Department of Radiation Oncology, Duke University School of Medicine, Durham, NC 27710, USA
    J Am Coll Radiol 3:793-8. 2006
    ....
  55. ncbi request reprint Hypofractionation for prostate cancer: a critical review
    Edward F Miles
    Department of Radiation Oncology, Duke University School of Medicine, Durham, NC 27710, USA
    Semin Radiat Oncol 18:41-7. 2008
    ..Until these trials are completed and the results submitted for rigorous peer review, the notion that alpha/beta for prostate cancer is low remains an unconfirmed hypothesis...